Search Results

1 - 10 of 261
Staff
Dr. Julie Segre is chief and a senior investigator in the Translational and Functional Genomics Branch at the National Human Genome Research Institute. ​
… tools to track hospital-acquired infections of multi-drug resistant organisms, including the NIH's recent … reconstructed a polymicrobial outbreak of multi-drug resistant Acinetobacter baumannii that swept through the … microbiome, bacterial pathogens, DNA sequencing, drug resistence … Dr. Julie Segre is chief and a senior …
Archive
… New Paradigm Will Help Identify Leads for Drug Discovery … Archive …
News Release
SJS/TEN is a severe drug reactions that affect the skin, and one of the most severe of adverse reactions affecting any system in the body
… Necrolysis (SJS/TEN). SJS/TEN is the severest of adverse drug reactions that affect the skin, and one of the most … organized a workshop , in collaboration with the Food and Drug Administration (FDA) and other NIH institutes, to … factors that predispose patients to severe immune mediated drug reactions like SJS/TEN, as well as studying the …
News Release
Researchers are asking if the precision medicine approach will reduce or eliminate the role that race plays in prescribing drugs and in health care overall.
… the complex interplay of ancestry, health, disease and drug response. … In a May 26 New England Journal of Medicine … prescribing drugs and in health care overall. "We focus on drug therapies because that's where the precision medicine … imprecise prescribing practices. This means including in drug studies people from diverse social, racial and ethnic, …
News Release
NIH researchers have identified a treatment that significantly decreases the risk of stroke in children with a rare genetic disease called Deficiency of Adenosine Deaminase Type 2 (DADA2).
… reason. … Benefits of the Treatment … Anti-inflammatory drug halts strokes in children with rare disease … NIH …
Archive
… NHGRI Researchers Create New Database of Drug-Metabolizing Enzymes … Archive …
Archive
… Gene-disease association data could improve drug development … Archive …
Archive
… 2001: FDA Approves Genetics-based Drug to Treat Leukemia … Archive …
News Release
Investigators with The Cancer Genome Atlas have discovered genomic differences in head and neck cancers caused by infection with the human papillomavirus.
… new smoking-related cancer subtypes and potential new drug targets, and found numerous genomic similarities with … of the National Institutes of Health. The U.S. Food and Drug Administration-approved HPV vaccines should be able to … The investigators also discovered new clues about drug resistance in head and neck cancers. They found that …